Literature DB >> 8738388

Type IV collagenase activity and cavernous sinus invasion in human pituitary adenomas.

H Kawamoto1, T Uozumi, K Kawamoto, K Arita, T Yano, T Hirohata.   

Abstract

Pituitary adenomas are regarded generally as benign tumours, but some of them can invade the cavernous sinus. On the other hand, matrix metalloproteinase-9 (MMP-9), which is a type IV collagenase, recently has been found to be expressed in matastases and to be related to the invasiveness of various malignant tumours including brain tumours. In order to investigate some characteristic features of pituitary adenomas which invade the cavernous sinus, we examined immunohistological studies for MMP-9 in seven pituitary adenomas for type IV collagen in a dura mater and assayed for type IV collagenase activity in seven adenomas using type IV collagen labelled with fluorescein isothiocyaniate (FITC). We found immunopositive adenoma cells for MMP-9 in all invasive adenoma and immunopositive spindle like cells for type IV collagen in the dura mater. All three invasive adenomas had high levels of type IV collagenase activity (0.57-0.72 U/ml), but the four adenomas which did not invade the cavernous sinus had low levels of type IV collagenase activity (0.0-0.10 U/ml). These results suggest that the level of type IV collagenase activity in a pituitary adenoma may be related to its ability to invade the cavernous sinus.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8738388     DOI: 10.1007/bf01420300

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  19 in total

1.  A rapid assay method of collagenase activity using 14C-labeled soluble collagen as substrate.

Authors:  K Terato; Y Nagai; K Kawanishi; S Yamamoto
Journal:  Biochim Biophys Acta       Date:  1976-10-11

2.  Experimental evaluation of bilayered human collagen as a dural substitute.

Authors:  A Laquerriere; J Yun; J Tiollier; J Hemet; M Tadie
Journal:  J Neurosurg       Date:  1993-03       Impact factor: 5.115

Review 3.  Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using an in vitro matrigel model.

Authors:  J S Rao; P A Steck; P Tofilon; D Boyd; F Ali-Osman; W G Stetler-Stevenson; L A Liotta; R Sawaya
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

4.  The collagenase activities, interstitial collagenase and type IV collagenase, in human stomach cancer: with special reference to local spreading and lymph node metastasis.

Authors:  Y Otani
Journal:  Keio J Med       Date:  1990-09

5.  Preferential digestion of basement membrane collagen by an enzyme derived from a metastatic murine tumor.

Authors:  L A Liotta; S Abe; P G Robey; G R Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

Review 6.  Tumoral invasion in the central nervous system.

Authors:  Y A De Clerck; H Shimada; I Gonzalez-Gomez; C Raffel
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

7.  Microprolactinoma invading the cavernous sinus--report of three cases.

Authors:  T Hirohata; T Uozumi; K Mukada; K Arita; K Kurisu; M Sumida; T Yano; A Takechi; J Onda
Journal:  Neurol Med Chir (Tokyo)       Date:  1992-01       Impact factor: 1.742

8.  Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants.

Authors:  E Marbaix; J Donnez; P J Courtoy; Y Eeckhout
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

9.  Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion.

Authors:  H Watanabe; I Nakanishi; K Yamashita; T Hayakawa; Y Okada
Journal:  J Cell Sci       Date:  1993-04       Impact factor: 5.285

10.  Basement membrane structure in situ: evidence for lateral associations in the type IV collagen network.

Authors:  P D Yurchenco; G C Ruben
Journal:  J Cell Biol       Date:  1987-12       Impact factor: 10.539

View more
  16 in total

1.  The expression of interleukin (IL)-17 and IL-17 receptor and MMP-9 in human pituitary adenomas.

Authors:  Lubin Qiu; Dongsheng He; Xiang Fan; Zhi Li; Chuangxin Liao; Yonghong Zhu; Haijun Wang
Journal:  Pituitary       Date:  2011-09       Impact factor: 4.107

2.  Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line.

Authors:  Isa M Hussaini; Christy Trotter; Yunge Zhao; Rana Abdel-Fattah; Samson Amos; Aizhen Xiao; Crystal U Agi; Gerard T Redpath; Zixing Fang; Gilberto K K Leung; Maria Beatriz S Lopes; Edward R Laws
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

3.  Expression of matrix metalloproteinase-9, type IV collagen and vascular endothelial growth factor in adamantinous craniopharyngioma.

Authors:  Zhiqiang Xia; Wenqing Liu; Shengdong Li; Ge Jia; Yuqi Zhang; Chunde Li; Zhenyu Ma; Jihui Tian; Jian Gong
Journal:  Neurochem Res       Date:  2011-08-04       Impact factor: 3.996

4.  Matrix metalloproteinase-9 secretion by human pituitary adenomas detected by cell immunoblot analysis.

Authors:  H Kawamoto; K Kawamoto; T Mizoue; T Uozumi; K Arita; K Kurisu
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

5.  Expression of epithelial cadherin and cavernous sinus invasion in human pituitary adenomas.

Authors:  H Kawamoto; T Mizoue; K Arita; A Tominaga; K Eguchi; K Kurisu
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

6.  Matrix metalloproteinase 2 (MMP-2) levels are increased in active acromegaly patients.

Authors:  Alper Cagri Karci; Zeynep Canturk; Ilhan Tarkun; Berrin Cetinarslan
Journal:  Endocrine       Date:  2017-03-22       Impact factor: 3.633

Review 7.  Emerging Histopathological and Genetic Parameters of Pituitary Adenomas: Clinical Impact and Recommendation for Future WHO Classification.

Authors:  W Saeger; S Petersenn; C Schöfl; U J Knappe; M Theodoropoulou; R Buslei; J Honegger
Journal:  Endocr Pathol       Date:  2016-06       Impact factor: 3.943

8.  Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas.

Authors:  Jian Gong; Yunge Zhao; Rana Abdel-Fattah; Samson Amos; Aizhen Xiao; M Beatriz S Lopes; Isa M Hussaini; Edward R Laws
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

9.  The Pituitary Tumors and Their Tumor-Specific Microenvironment.

Authors:  M M Kameda-Smith; J -Q Lu
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

10.  Acute elevation of interleukin 6 and matrix metalloproteinase 9 during the onset of pituitary apoplexy in Cushing's disease.

Authors:  Takako Araki; Jutarat Sangtian; Darin Ruanpeng; Ramachandra Tummala; Brent Clark; Lynn Burmeister; Daniel Peterson; Andrew S Venteicher; Yasuhiko Kawakami
Journal:  Pituitary       Date:  2021-05-26       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.